Celltrion Healthcare ranked among the top searched stocks on 8 days within the past month.

As of 2:30 PM on the 12th, Celltrion Healthcare is trading at 104,100 KRW, down 3.97% from the previous day. This represents a 10.16% increase compared to July 31. Celltrion Healthcare is known as the exclusive distributor of biosimilars for Celltrion.

Today, foreigners have a net sell of 11,000 shares of Celltrion Healthcare, and institutions have a net sell of 26,000 shares, according to provisional data. Over the past 5 days, individual investors have net sold 900,529 shares, while foreigners and institutions have net sold 118,671 shares and net bought 989,473 shares, respectively.

On August 10, Celltrion Healthcare was a market topic with the headline "Rising trend expected due to biosimilar benefits."



[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)
※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing